Physician

David Stanley, MD

According to 2025 Medicare claims, David Stanley, MD (NPI: 1184820722) practices urology in the Gainesville, GA market, with the plurality of this provider's patient population coming from Hall, GA. This provider's primary affiliated billing organization is GEORGIA UROLOGY PA (NPI: 1245250646; TIN: 582483742) and primary practice location at 30501-2418.

Stanley's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 596 traditional Medicare patients, billed 6,324 HCPCS/CPT codes, and received $188,236 in Medicare payments. The top billing code was 52000 (Diagnostic exam of bladder and urethra using an endoscope). Part D data shows 1,943 prescription claims across 604 beneficiaries totaling $132,483 in drug costs, led by Myrbetriq (Mirabegron). DME data shows 101 claims. Open Payments data shows 27 records totaling $794. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $53,298 to $188,236. Similarly, Part D prescription costs have moved sharply higher in recent years, from $12,930 to $132,483. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	193	701	$53,298
2019	420	2,231	$153,067
2020	478	1,809	$105,042
2021	515	5,688	$180,944
2022	581	4,958	$195,663
2023	594	5,062	$187,049
2024	596	6,324	$188,236

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	101	214	$12,930
2019	231	646	$23,211
2020	235	540	$25,468
2021	361	983	$78,679
2022	474	1,447	$84,587
2023	559	1,668	$102,216
2024	604	1,943	$132,483

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	48	$7,349
2017	N/R	30	$3,421
2018	N/R	13	$3,630
2019	N/R	12	$2,453
2020	N/R	24	$5,289
2021	N/R	28	$6,114
2022	N/R	37	$37,312
2023	N/R	75	$62,874
2024	14	101	$58,885

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
52000	Diagnostic exam of bladder and urethra using an endoscope	150	181	$156
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	332	456	$86
36415	Insertion of needle into vein for collection of blood sample	132	163	$9
81015	Urinalysis using microscope	160	264	$3
81003	Automated urinalysis test	148	187	$2

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Myrbetriq	Mirabegron	56	3,611	$52,544
Gemtesa	Vibegron	41	2,130	$33,703
Tamsulosin Hcl	Tamsulosin Hcl	549	38,939	$5,767
Estradiol	Estradiol	79	5,473	$5,062
Solifenacin Succinate	Solifenacin Succinate	150	7,641	$4,020

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4352	Intermittent urinary catheter; coude (curved) tip, with or without coating (teflon, silicone, silicone elastomeric, or hydrophilic, etc.), each	N	N/R	13	$31,259
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	14	66	$27,510
A4402	Lubricant, per ounce	N	N/R	22	$116

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	27	$794	PROCEPT BioRobotics Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for David Stanley, MD?

Tedicare shows public-source Medicare data for David Stanley, MD (NPI 1184820722), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David Stanley, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to David Stanley, MD?

David Stanley, MD is linked to GEORGIA UROLOGY PA (billing NPI 1245250646) in the available physician profile data.

Does David Stanley, MD have Open Payments data?

David Stanley, MD has 27 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.